Healthcare -
Biotechnology - NASDAQ - US
$ 684.01
0.136 %
$ 73.9 B
Market Cap
16.93
P/E
REGN - OPERATING EXPENSES
Operating Expenses REGN - Regeneron Pharmaceuticals, Inc.
7.25 B
LAST VALUE
24.40%
2 YEAR CAGR
14.15%
5 YEAR CAGR
19.82%
10 YEAR CAGR